Cargando…

High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes

BACKGROUND: Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes (T1D). A pro-calcific drift of circulating monocytes has been linked to vascular calcification and is marked by the surface expression of osteocalcin (OCN). We studied OCN+ monocytes in a unique population with...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddaloni, Ernesto, Xia, Yu, Park, Kyoungmin, D’Eon, Stephanie, Tinsley, Liane J., St-Louis, Ronald, Khamaisi, Mogher, Li, Qian, King, George L., Keenan, Hillary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602856/
https://www.ncbi.nlm.nih.gov/pubmed/28915881
http://dx.doi.org/10.1186/s12933-017-0599-2
_version_ 1783264634948550656
author Maddaloni, Ernesto
Xia, Yu
Park, Kyoungmin
D’Eon, Stephanie
Tinsley, Liane J.
St-Louis, Ronald
Khamaisi, Mogher
Li, Qian
King, George L.
Keenan, Hillary A.
author_facet Maddaloni, Ernesto
Xia, Yu
Park, Kyoungmin
D’Eon, Stephanie
Tinsley, Liane J.
St-Louis, Ronald
Khamaisi, Mogher
Li, Qian
King, George L.
Keenan, Hillary A.
author_sort Maddaloni, Ernesto
collection PubMed
description BACKGROUND: Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes (T1D). A pro-calcific drift of circulating monocytes has been linked to vascular calcification and is marked by the surface expression of osteocalcin (OCN). We studied OCN+ monocytes in a unique population with ≥50 years of T1D, the 50-Year Joslin Medalists (J50M). METHODS: CD45 bright/CD14+/OCN+ cells in the circulating mononuclear blood cell fraction were quantified by flow cytometry and reported as percentage of CD45 bright cells. Mechanisms were studied by inducing OCN expression in human monocytes in vitro. RESULTS: Subjects without history of CVD (n = 16) showed lower levels of OCN+ monocytes than subjects with CVD (n = 14) (13.1 ± 8.4% vs 19.9 ± 6.4%, p = 0.02). OCN+ monocytes level was inversely related to total high density lipoprotein (HDL) cholesterol levels (r = −0.424, p = 0.02), large (r = −0.413, p = 0.02) and intermediate (r = −0.445, p = 0.01) HDL sub-fractions, but not to small HDL. In vitro, incubation with OxLDL significantly increased the number of OCN+ monocytes (p < 0.01). This action of OxLDL was significantly reduced by the addition of HDL in a concentration dependent manner (p < 0.001). Inhibition of the scavenger receptor B1 reduced the effects of both OxLDL and HDL (p < 0.05). CONCLUSIONS: Low OCN+ monocytes levels are associated with lack of CVD in people with long duration T1D. A possible mechanism for the increased OCN+ monocytes could be the elevated levels of oxidized lipids due to diabetes which may be inhibited by HDL. These findings suggest that circulating OCN+ monocytes could be a marker for vascular disease in diabetic patients and possibly modified by HDL elevation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-017-0599-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5602856
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56028562017-09-20 High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes Maddaloni, Ernesto Xia, Yu Park, Kyoungmin D’Eon, Stephanie Tinsley, Liane J. St-Louis, Ronald Khamaisi, Mogher Li, Qian King, George L. Keenan, Hillary A. Cardiovasc Diabetol Original Investigation BACKGROUND: Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes (T1D). A pro-calcific drift of circulating monocytes has been linked to vascular calcification and is marked by the surface expression of osteocalcin (OCN). We studied OCN+ monocytes in a unique population with ≥50 years of T1D, the 50-Year Joslin Medalists (J50M). METHODS: CD45 bright/CD14+/OCN+ cells in the circulating mononuclear blood cell fraction were quantified by flow cytometry and reported as percentage of CD45 bright cells. Mechanisms were studied by inducing OCN expression in human monocytes in vitro. RESULTS: Subjects without history of CVD (n = 16) showed lower levels of OCN+ monocytes than subjects with CVD (n = 14) (13.1 ± 8.4% vs 19.9 ± 6.4%, p = 0.02). OCN+ monocytes level was inversely related to total high density lipoprotein (HDL) cholesterol levels (r = −0.424, p = 0.02), large (r = −0.413, p = 0.02) and intermediate (r = −0.445, p = 0.01) HDL sub-fractions, but not to small HDL. In vitro, incubation with OxLDL significantly increased the number of OCN+ monocytes (p < 0.01). This action of OxLDL was significantly reduced by the addition of HDL in a concentration dependent manner (p < 0.001). Inhibition of the scavenger receptor B1 reduced the effects of both OxLDL and HDL (p < 0.05). CONCLUSIONS: Low OCN+ monocytes levels are associated with lack of CVD in people with long duration T1D. A possible mechanism for the increased OCN+ monocytes could be the elevated levels of oxidized lipids due to diabetes which may be inhibited by HDL. These findings suggest that circulating OCN+ monocytes could be a marker for vascular disease in diabetic patients and possibly modified by HDL elevation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-017-0599-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-09-16 /pmc/articles/PMC5602856/ /pubmed/28915881 http://dx.doi.org/10.1186/s12933-017-0599-2 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Maddaloni, Ernesto
Xia, Yu
Park, Kyoungmin
D’Eon, Stephanie
Tinsley, Liane J.
St-Louis, Ronald
Khamaisi, Mogher
Li, Qian
King, George L.
Keenan, Hillary A.
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
title High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
title_full High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
title_fullStr High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
title_full_unstemmed High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
title_short High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
title_sort high density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602856/
https://www.ncbi.nlm.nih.gov/pubmed/28915881
http://dx.doi.org/10.1186/s12933-017-0599-2
work_keys_str_mv AT maddaloniernesto highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT xiayu highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT parkkyoungmin highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT deonstephanie highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT tinsleylianej highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT stlouisronald highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT khamaisimogher highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT liqian highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT kinggeorgel highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes
AT keenanhillarya highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes